Methylprednisolon (kutan)
Generic name
Methylprednisolon (kutan)
Brand name
ATC Code
D07AC14
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Bei drei atopischen Kindern (im Alter von 9-10 Jahren) betrug die perkutane Resorption von Methylprednisolonaceponat aus der Advantan Fettsalbe ca. 0,5 - 2% und war somit nicht höher als bei Erwachsenen (SmPC Advantan 0,1 % Fettsalbe).
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Atopic dermatitis |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Do not use under occlusive conditions. Diapers can act like an occlusive dressing. Use glucocorticoids only as long and only in such low doses, especially in children, as is absolutely necessary to achieve and maintain the desired therapeutic effect.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
CORTICOSTEROIDS, PLAIN
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Corticosteroids, weak (group I) | ||
|---|---|---|
| D07AA02 | ||
| Corticosteroids, moderately potent (group II) | ||
|---|---|---|
| D07AB01 | ||
| D07AB02 | ||
| D07AB09 | ||
| Corticosteroids, potent (group III) | ||
|---|---|---|
| D07AC01 | ||
| D07AC03 | ||
| D07AC17 | ||
| D07AC13 | ||
| D07AC18 | ||
| Corticosteroids, very potent (group IV) | ||
|---|---|---|
| D07AD01 | ||
References
- LEO Pharma, SmPC Advantan 0,1 % Salbe (1-19576), 07-2019
- LEO Pharma, SmPC Advantan 0,1 % Milch (1-22211), 07-2019
Changes
Therapeutic Drug Monitoring
Overdose
